Forecasting
#2Pharmacy Trend Forecast Engine
Forecast prescription drug inflation with pipeline intelligence
Pharmacy Cost Trend Analysis
Trend Forecast
Current Net Cost
$4.5M
Projected Net Cost
$6.4M
Net Cost Growth
42.5%
PMPM Growth
42.1%
Per Member Per Month (PMPM) Trend
Solid = Historical
Dashed = Projected
Drug Mix Distribution
Cost allocation across generic, brand, and specialty medications
Generic45%
Brand30%
Specialty25%
Drug Pipeline Financial Impact
Expected cost impact from FDA pipeline drugs entering the market
GLP-1s
Probability: 85%
+$0.8M
Biosimilars
Probability: 75%
$0.4M
Gene Therapy
Probability: 45%
+$0.3M
Oncology
Probability: 70%
+$0.7M
Overview
Pharmaceutical cost forecasting engine that integrates FDA drug pipeline data, biosimilar adoption curves, patent expiration schedules, manufacturer rebate agreements, and formulary management strategies to project pharmacy trends 12-24 months forward with scenario modeling.
Key Capabilities
- Drug pipeline impact modeling (GLP-1, oncology, gene therapy)
- Biosimilar adoption and displacement curves
- Specialty vs. traditional cost attribution
- Rebate erosion and contract change impact
- Generic dispensing rate optimization
- Manufacturer assistance program integration
- Utilization management effectiveness modeling
Required Inputs
- •Historical pharmacy claims (NDC-level detail)
- •Current formulary and tier structure
- •PBM contract terms and rebate guarantees
- •FDA drug pipeline (approvals, LOE dates)
- •Member demographics and diagnosis codes
- •Specialty pharmacy enrollment
- •Prior authorization and step therapy rules
Generated Outputs
- •Gross and net pharmacy cost projections
- •PMPM and PEPY trend rates by drug class
- •Specialty pharmacy cost forecasts
- •Rebate value projections and contract ROI
- •Generic conversion opportunity quantification
- •Pipeline drug financial impact scenarios
- •Formulary optimization recommendations